← Open Payments lookup

J CATES: Open Payments

NPI 1760543714 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,499 in 127 payments from 12 companies in 2025. Trend: 2023 $2,021 · 2024 $2,451 · 2025 $2,499

Food & beverage: $2,499
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc34$742
Alkermes, Inc.24$379
Teva Pharmaceuticals USA, Inc.16$295
Axsome Therapeutics, Inc.11$268
Indivior Inc.13$220
Neurocrine BioSciences, Inc.10$216
Otsuka America Pharmaceutical, Inc.6$109
Braeburn Inc.3$84
Vanda Pharmaceuticals Inc.3$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$55

Products named: INVEGA SUSTENNA, ARISTADA, UZEDY, Auvelity, SUBLOCADE, INGREZZA, SPRAVATO, BRIXADI.

Industry payments across OK — which companies pay providers there.